T. Rowe Price Investment Management, Inc. 13D and 13G filings for Insmed Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-02-16 5:43 pm Sale |
2023-12-31 | 13G | Insmed Incorporated INSM |
T. Rowe Price Investment Management, Inc. | 5,850,606 4.100% |
-27,378,148![]() (-82.39%) |
Filing |
2024-02-14 10:04 am Purchase |
2023-12-31 | 13G | Insmed Incorporated INSM |
T. Rowe Price Investment Management, Inc. | 33,228,754 4.100% |
24,854,079![]() (+296.78%) |
Filing |
2023-02-14 12:40 pm Purchase |
2022-12-31 | 13G | Insmed Incorporated INSM |
T. Rowe Price Investment Management, Inc. | 8,374,675 6.200% |
8,374,675![]() (New Position) |
Filing |